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Thesis Overview 
 
The excellent biocompatibility and osteointegration properties of calcium 
phosphate-based materials in different forms ranging from dense to 
porous bodies or as granules and coatings is well utilised in dental and 
skeletal prosthetic applications. Hydroxyapatite (HA- Ca5 (PO4)3(OH)) and 
beta tricalcium phosphate (βTCP, β-Ca3(PO4)3) are typically used 
compositions in biomedical applications due to their chemical similarity to 
the inorganic component of human bone and teeth. It is to be noted that 
human hard tissues are not pure HA or βTCP and it contain other organic 
compounds (collagen and non - collagenous proteins) and inorganic 
phosphates as well, which are isomorphically substituted by several ions 
like Mg2+, Sr2+, Na+, K+ etc. in trace level. It is now well known that the 
presence of such trace elements plays an essential role in biological 
metabolism, and their introduction in synthetic biomaterials can modify 
and even improve the biocompatibility and osteointegration process.       
The raw materials used for hard tissue bioengineering applications are 
typically calcium phosphate ceramic powders. Different production 
methods, including solid-state, hydro-thermal and wet chemical processes 
have been developed for their synthesis. Among these approaches, solid-
state route is preferred mainly because of its simplicity and lower number 
of controlling parameters. Other techniques require obeying several strict 
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processing conditions like reaction temperature, time and solution pH; a 
slight variation of any of these conditions can cause the formation of other 
phosphate phases, which are undesirable.     
This PhD work mainly focus on the synthesis and characterization of 
calcium phosphate powders for plasma spray coating. The preparation of 
high temperature phase stabilized βTCP and HA/βTCP powders for plasma 
spray coating applications has been the topic of investigation.  Nowadays 
plasma sprayed coatings are widely used for biomedical applications 
especially in the dental and orthopaedic implantation field. Previously Ti 
based alloys were widely used for the orthopaedic and dental implant 
applications because of its high corrosion and good biocompatibility. Due 
to the limited osteoconductivity edges of Ti implants with fibrous tissues 
delays the healing time. To overcome these limitations different types of 
surface modification processes are employed on the surface of Ti. The 
coating of HA is a widely used surface modification technique due to its 
excellent biological properties. HA is a well employed bone graft material 
due to its similarity with human hard tissues. The plasma spraying of HA on 
the Ti surface is the most widely used technique mainly due to its process 
simplicity, low cost and bulk production.   
The present research focuses on the modification of HA coatings for the 
improvement of bio-degradation properties of HA. HA/βTCP composite 
powders are used to overcome the poor biodegradation properties of HA. 
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The issue related to the use of βTCP is the phase transformation (β to α) at 
high temperature. To overcome this phase transformation, the βTCP 
powder was doped with MgO. The high temperature phase stabilized MgO 
doped βTCP and HA/βTCP powders were synthesized by solid state method 
and granulated using spray granulation. The properties of the granulated 
powders (100-150μm) were analysed with XRD, FT-IR, SEM, flowabilty, 
density etc. and are used in plasma spray coating process. The produced 
coatings were subjected to the thermal treatment and βTCP and HA/βTCP 
plasma sprayed coatings are obtained. The successively produced coatings 
were characterized, and the invitro properties like solubility and bioactivity 
behaviours were studied.  
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Chapter 1: Introduction 
 
The end of the 19th century witnessed the introduction of the concept of 
aseptic surgery, and its further development led to the possibility of 
implanting foreign material into the human body with an acceptably low 
risk of rejection due to infections. Nevertheless, at this time no suitable 
material was existing, which could withstand the challenges caused by the 
biological environment. Later on, in the first half of 20th century improved 
materials were developed and were used in the surgical applications. The 
materials currently in use are those that have performed tolerably in 
clinical situations. Inter alia, the developments in the field of biomaterial 
research over the past 20 years had a great influence on the technologic 
advances in this regard. A biomaterial is any matter, surface or construct 
that interacts with human biological systems. In the present epoch, the 
biomaterial science is a well-developed and expanded area of research and 
a huge amount of money is invested by industry for the development of 
biomaterials. Also biomaterial research has become an interdisciplinary 
area comprising almost all areas of scientific research including medicine, 
biology, chemistry, tissue engineering and material science.  
A biomaterial can communicate with human tissues and body fluids to 
improve or replace the morphology and structure of a human body. Over 
the past few decades, the advent of artificial implantation has ushered 
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several advances in the biomedical field. Biomaterials can be derived either 
from nature or can be produced in the laboratory using different chemical 
approaches involving metallic and non metallic components, polymers, 
ceramics and composite materials. Nowadays, biomaterials are widely 
used in joint replacement, bone plates, bone cement, artificial ligaments, 
tendons, dental implants, blood vessel prostheses and heart valves. Also 
they find application in skin repair devices (artificial tissue), cochlear 
replacements, contact lenses, breast implants, drug delivery mechanisms, 
sustainable materials, vascular grafts, and nerve conduits. Figure 1 shows 
the applications of biomaterials in the human body. 
Biocompatibility plays an important role in the application of biomaterial 
products, because it must be adaptable in human body and should not be 
rejected by the human immune system. Due to the high demand for 
synthetic biomaterials to assist and replace skeletal tissue, and the high 
failure rates of these medical implants, a great deal of research focuses on 
improving the strength of implant tissue interface and in the design of 
implants that degrade in concert with the natural healing process. Artificial 
soft tissues and organs are the products of the recent bio-medical 
research. The artificial materials are synthesized mainly from bio active 
materials with similar properties of human soft and hard tissues. Research 
on the development of new biomaterials includes the use of the present 
materials in a new composite material with enhanced properties, 
  
 Page 13 
 
modification of the structure of the present biomaterials and the chemical 
synthesis of new biomaterials. [1, 2]  
 
 
 
 
 
 
 
 
 
Figure 1: Applications of biomaterials in the human body an over view 
[81] 
 
Particularly, orthopaedic implants constitute a major part in the biomedical 
implantation. The increase in the implants percentage boosts more 
exploration in this area. 
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1.1. Orthopaedic implants 
 
Orthopaedic implants can be defined as medical devices used to replace or 
provide fixation of bone, or articulating surface of a joint. The final success 
and life time of orthopaedic implants are determined by the bone-implant 
reaction with human body or tissue.  Nowadays orthopaedic implants are 
available for hip, knee, shoulder and elbow.  
 
 
 
 
 
 
 
 
Figure 2: Applications of orthopedic implants in the human body 
(Source: http://www.onxlti.com/product-divisions/contract-manufacturing-
products/orthopedic-applications/) 
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Till date, the best available materials for orthopaedic implants are titanium 
and calcium phosphate ceramics. [3,4] 
1.2. Bioceramics 
Table 1: Different types of bioceramics and its properties [5]. 
Type of Bioceramics Properties Example 
Non absorbable 
(relatively inert) 
Attach by bone growth 
into surface 
irregularities by 
cementing the device 
in to the tissues or by 
press fitting into a 
defect (morphological 
fixation) 
 
Al2O3, Zirconia, Silicon 
nitrides and carbons 
Bioactive and surface 
reactive (semi inert) 
Direct chemical bond 
with bone. (Bioactive 
fixation) 
 
Dense hydroxyapatite 
 and glass ceramics 
 
Biodegradable or 
resorbable 
Slowly replaced by 
bone 
Tricalcium phosphate, 
Calcium phosphate 
salts and Calcium 
sulphate (plaster of 
paris) 
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A ceramic is an inorganic non metallic solid prepared by the action of heat 
with consecutive cooling. Mostly, they have crystalline nature and some of 
them are amorphous. In the recent years, we have realized that ceramics 
and their composites can also be used to augment or replace various parts 
of the human body, especially hard body parts like bone and teeth, 
because of its biocompatibility nature and structural properties. The 
ceramics which are used in the biomedical applications are called bio-
ceramics. The main advantage of bio-ceramics is its high compatibility with 
human body environment and the fact that it contains ions, which are 
commonly found in the body tissues. The advantage of the ceramic 
material is the comparatively faster bond formation between the tissue 
and the material. Bioceramics are classified into four groups based on the 
types of attachment to the surrounding tissues. Table 1 shows the 
different types of bioceramics, properties and examples. [5] [6]  
 
1.3. Biodegradable or resorbable ceramics 
 
Resorbable ceramics, as the name implies, degrade upon implantation in 
the body. The rate of degradation varies with the property of the 
implanting material. Tricalcium phosphate, plaster of paris, hydroxyapatite, 
corallines, etc. are the examples of easily available resorbable biomaterials. 
Implantation failures due to infection and other biological issues with 
  
 Page 17 
 
human body are well surpassed by calcium phosphate because of its 
excellent properties comparable with human soft and hard tissues. [5] 
 
1.4. Calcium Phosphate (CaP) 
 
The excellent biocompatibility and osteointegration properties of calcium 
phosphate based materials in different forms ranging from dense to 
porous bodies or granules and coating is well utilised in dental and skeletal 
prosthetic applications. The surface reactivity of calcium phosphate based 
materials contribute to the bone bonding ability and increased the new 
bone tissue formation. Also these materials are non toxic and they will not 
cause the death of surrounding tissues.  The main advantage of calcium 
phosphate is that, it is already present in the human body in different 
biological systems. Table 2 shows the different types of calcium 
phosphates in the human biological system. 
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Calcium phosphates Occurrence 
Amorphous calcium phosphates 
(ACP) 
Soft- tissue calcification 
Dicalcium phosphate dihydrate 
(DCPD) 
Dental calculus, dental caries 
Octacalcium phosphate (OCP) Dental calculus, urinary stone 
Mg-substituted tricalcium 
phosphate (βTCMP) 
Dental calculus, soft tissue 
calcification 
Carbonate hydroxyapatite (CHA) Dental calculus, urinary stone, 
mineral phase of enamel, dentin, 
cementum, bone, fish enameloids 
Carbonate fluroapatite (CFA),  
Calcium pyrophosphate dihydrate 
(CPPD) 
 
Fish enameloids 
 
The main advantages of calcium phosphate in biomedical applications are 
1) The ability for the formation of new bone apatite like minerals on 
the surface. 
2) The structural similarity and phase composition with human hard 
tissue minerals.  
3) The ability of releasing Ca and phosphorous ions and the solubility 
which boosts the cellular function and new bone formation.  
Table 2: Applications of calcium phosphate in biological systems [77] 
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4) The resorbability property of calcium phosphate which helps the 
formation and reabsorption occurring in the bone tissue. 
The raw materials for bioengineering applications are typically calcium 
phosphate ceramic powders. The utilisation of synthetic calcium 
phosphates in multi functional biomedical applications such as 
orthopaedic, aesthetic, healing bone defects, bio imaging etc was a major 
breakthrough in recent years. Calcium phosphates are categorised 
depending up on the chemical composition with respect to the Ca/P molar 
ratio and solubility. Commonly calcium phosphates containing lower Ca/P 
ratio are more acidic and hence more soluble in body fluids.  
 
 
Table 3: Existing calcium phosphate and their major properties[78,79] 
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Calcium phosphate can be divided into different compounds depending on 
the chemical compositions associated to the molar Ca/P ratio and 
solubility. In general as lower the ratio Ca/P is more acidic and more 
soluble become in the water. Hydroxyapatite (HA) and β-tricalcium 
phosphate (βTCP) are the most stable and least soluble calcium phosphate 
from the group (table 3) because of this nature they are commonly used 
for biomedical applications.   
1.5. Hydroxyapatite 
 
Over the past years, hydroxyapatite (hydroxylapatite- Ca10 ((PO4)6(OH)2) 
received much attention as a replacing material for damaged bone and 
teeth in the human body because of its similar structural and chemical 
properties with human tissues. It is the most stable calcium phosphate and 
show excellent biological properties. HA crystallises in hexagonal structure 
with lattice parameter value a = 9.5Å and c = 6.8Å. The crystal structure of 
HA (figure.3) explains the hexagonal structure of PO4
3- tetrahedron 
creating two kinds of tunnels parallel to the c - axis. The first type of tunnel 
like structure is filled with Ca2+(A) ions which form CaO9
- polyhedra, 
whereas the other type, which is lined by oxygen and other Ca ions, is 
occupied by OH- anions. The second type of calcium ions forms the triangle 
at z = ¼ and z = ¾ . Three ions of Ca2+ in the corners of the triangle is 
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bonded with central OH- anion in the tunnel which is placed below or 
above of the triangular plane. [7,8] 
 
 
Figure 3: Crystal structure of hydroxyapatite after Wilson et al. projected 
perpendicular to c-axis. (b) Crystal structure of hydroxyapatite after 
Wilson et al. projected on (001). [7] 
Within the CaP family HA shows an excellent biological capability and 
surface active nature with living tissues and organs and it has become one 
of the promising materials for biomedical application. Likewise, nano 
particles and porous based HA are good candidates for drug delivery and 
HA column is used for the separation of RNA and DNA from the biological 
samples.  HA is also an efficient catalyst due to its astonishing properties 
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like ion exchange ability, adsorption capacity, non-toxicity, acidic base 
properties and thermal stability. [1,2,9–11] 
The Ca/P ratio in HA is 1.67 and small variation in this value will affect the 
stability of HA in the temperature treatment. The lattice of HA can easily 
incorporate different types of substituent in the apatite structure, which in 
turn leads to the modification in crystalline properties, morphology, lattice 
parameter and thermal stability. It is proved that trace amount of cations 
(Mg2+, Zn2+, Sr2+ etc) and anions (SiO4
4-, F-, CO3
2- etc) in apatite lattice plays 
a decisive role in its biological performance upon implantation. Different 
types of synthetic methods are used for the preparation HA, which 
depends upon the properties like, size, crystalline nature and shape of HA. 
Among them, precipitation, solid state, micro emulsion etc. are the main 
used strategies. [8, 12–14] 
The fabrication of stable artificial bone implant interface is an important 
criterion for the success of dental and orthopaedic applications. The 
stability of implant material in the host body is influenced by some 
important parameters like design of the implant, recipient health, surgical 
technique and direct host implant effect. Different types of approaches 
have been developed to induce the favourable host to implant 
interactions, such as production of implant surface with microscopic 
irregularities, porous surface and osteoconductive coatings.[15–17]   
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Ti based alloys were widely used for orthopaedic implants because of its 
very high corrosion as well as fatigue resistance and its biocompatibility. 
Anyhow, less osteoconduction properties cause the encapsulation of Ti 
implants with fibrous tissue, which lag the healing process time. To 
overcome these limitations, Ti is employed with different surface 
modification processes to improve the osteoconductive properties. HA 
coating is widely used for the surface modification process and it helps to 
the faster bone regeneration compared to uncoated Ti surface.  HA coating 
stimulates new bone ingrowths through osteoconduction mechanism 
without causing any local or systemic toxicity and induces the natural bone 
formation around the implant. [4, 18–22] 
Nowadays, HA coatings are used for hip and knee replacing. Different 
coating process such as plasma spraying, sol-gel processing, electrical 
polarization, high-velocity oxy-fuel spray (HVOF) and aerosol deposition 
have been used to deposit HA coating onto Ti or its alloy substrate. 
Meanwhile, the long-term stability of HA coating is still a difficult problem. 
To overcome these problems, coatings should have good mechanical 
properties and high bonding strength interface between coating and 
metallic substrate. From the above coating techniques, plasma spraying 
has been successfully used as a reliable cost-effective solution and has 
attracted much attention in the recent years. [19]  
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It has been reported that, HA has a problem of very low biodegradation 
properties, which prevents the natural bone ingrowths for a longer time. 
The presence of βTCP increases the poor biodegradation properties of HA 
ceramics. The HA/βTCP composite is expected to increase the bone growth 
without changing the osteoconductive properties of HA. [23,24]  
1.6. Beta tricalcium phosphate (βTCP) 
 
βTCP emerged as one of the most imperative biomaterials because of its 
astonishing properties in terms of biocompatibility, in-vivo bioactivity, 
bioresorbability and osteoconductivity [25–28]. According to Dickens’ 
studies, the βTCP crystallises in the form of rhombohedral space group R3c 
with unit cell parameter a= 10.44Å and c= 37.38Å and the unit cell 
containing 21 formula units of Ca3 (PO4)2.  The structure of βTCP can be 
disturbed by different layers of PO4 tetrahedron and the Ca ion in the 
centres of this tetrahedron.  Figure 4 shows the crystalline structure of 
βTCP.  
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Figure 4: Crystal structure of β-tricalcium phosphate after Dickens et al. 
projected perpendicular to c-axis [7] 
Recently, biphasic calcium phosphate came to use in bone graft application 
because of its higher resorbability compared to the pure HA components. 
One fundamental issue related to the processing and use of βTCP is the 
phase transformation (from β to α phase) at high temperature. As a matter 
of fact, tricalcium phosphate exists in three different allotropic phases, β 
(T<1180°C), α (1180<T<1430°C) and α’ (T >1430°C). Due to β to α phase 
transformation, bio-restorability of TCP is reduced and this is not desirable 
for its application. The phase transition also decreases the densification 
and, thereby, the mechanical strength. β to α phase transformation can be 
affected by the stoichiometric Ca/P ratio. Any small change in the Ca/P 
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ratio affects the purity of TCP in the form of β phase. Therefore, in order to 
utilize the properties of TCP for practical applications, it is necessary to 
stabilize the β-phase at a high temperature. [29–33]   
The addition of mono- and divalent metal ions as dopants for TCP is found 
to stabilize the β phase at high temperature. The cations like (Mg2+, Zn2+, 
Sr2+ etc) and anions (SiO4
4-, F-, CO3
2- etc) are used for the phase stabilization 
of βTCP. Human hard tissue (enamel, dentins and bone) in turn contains 
trace amount of elements like K, Na, Mg, F, K, Zn and CO3 ions and hence 
this addition of metal ions will not affect the biological performance. Table 
4 shows the percentage of elements present in the human body. 
[26,32,34–36] 
 
 
 
 
 
 
Table 4:  Percentage of elements presented in the human body. [80] 
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1.7. Doping of βTCP 
 
Mg is one of the most common doping elements used for the biomedical 
applications because of its important role in biological systems. Mg 
associated biological apatite shows better performance than pure form. 
Reported studies showed that small amount of Mg (2mol%) enhances the 
bioactivity and biocompatibility of HA ceramics; Mg is also found in the 
human hard tissues. [28,33,37] 
MgO is a commonly used dopant for the β phase stabilization of TCP. The 
presence of Mg in TCP also improves properties like biocompatibility, 
density, mechanical strength etc [26–28,32,38–41]. Pan et al. found that 
small amount of MgO in the βTCP structure enhances the phase stability 
and improves the biocompatibility of TCP [29]. Mg2+ ions replace calcium 
(Ca2+) ions in βTCP structure and the obtained mineral phase is commonly 
known as whitlockite (β-TCMP) [38].  
The phase diagram of MgO doped βTCP shows the effect of incorporation 
of Mg ions on the βTCP lattice. At the synthesis temperature of 1025⁰C up 
to ~14 mol% Ca ions can replaced by Mg ions and due to this change the 
lattice parameter and crystallite size of βTCP is reduced.  
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Figure 5: Phase diagram of MgO doped βTCP synthesized at 1120⁰C [32] 
The phase transformation temperature of β to α polymorph increased 
from 1150⁰C without Mg2+ to 1540⁰C with 8 mol% substitution on the Ca2+ 
site. Samples with larger substitution than 10 mol% sintered at the 
temperature below 1600⁰C which implies that the further increase will not 
affect the phase transformation. [32] [42] 
We have already seen the applications of CaP based materials particularly 
in orthopaedic and dental implantations. CaP based coatings are used now 
mainly for the artificial implantation of human joints. Plasma spray coating 
is one of the common techniques, which is used for the coating process. 
[43–45] 
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1.8. Plasma Spray Coatings 
 
Thermal spraying techniques are well exploited coating process in 
multifunctional applications for industries. The main advantages of this 
type of coating are that advanced coating materials can be used and also 
coating and substrate material can be varied. Many surface problems of 
the materials can be resolved by this technique.  
Plasma spray is one of the most versatile thermal spray coating processes. 
This process is capable of spray all types of sprayable materials. In plasma 
spray, powder materials or sometimes liquid, is fed into the gas plasma 
stream. The plasma is produced by striking an electric arc between a figure 
type tungsten (W) cathode and a nozzle type copper anode inside the 
plasma torch. [18,44–47]  
The injected powder materials get melted because of the high 
temperature of plasma and highly accelerated samples were coated on the 
substrate surface for the development of lamellar structured coating. The 
high working temperature of the spray gases which is formed by the 
plasma process and the automation of plasma spray devices make it 
possible to produce high-quality coatings for a wide variety of applications. 
[15,43,48,49]  
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Figure 6: Process of plasma spray coatings 
(Source: http://www.advanced-coating.com/english/spraying-plasma.htm) 
 
Nowadays, plasma sprayed coatings are widely used for biomedical 
applications especially in the dental and orthopaedic implantation field. 
Previously, Ti based alloys were widely used for the orthopaedic and dental 
implant applications because of its high corrosion and good 
biocompatibility. Due to the limited osteoconductivity edges of Ti implants 
with fibrous tissues delays the healing time. To overcome these limitation's 
different types of surface modification processes are employed on the 
surface of Ti. The coating of HA is a widely used surface modification 
technique due to its excellent biological properties. HA is a well employed 
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bone graft material due to its similarity with human hard tissues. It is 
conceivable that plasma spraying of HA on the Ti surface is the most widely 
used technique due to its process simplicity, low-cost and bulk production.  
[6,20,43,46,49–56]   
The present research focus on the modification of calcium phosphate 
coatings with improved bio-degradation properties. Beta tricalcium 
phosphate (βTCP) has been used in clinical applications for its good micro-
porosity and higher biodegradation properties with respect to HA. 
Researchers have reported that the presence of βTCP helps to improve the 
properties of HA, like biocompatibility, osteoconductivity and 
biodegradation. In particular, the mixture of 40% of βTCP and 60% of HA 
produce better result that other compositions. [57–62] Based on these 
inferences, we decided to focus on the production of HA/βTCP plasma 
sprayed coatings. The studies showed that the transformation of β to α 
phase during the plasma spray process takes place because of the very 
high-temperature formation. [15]  
The aim of the present PhD work is to synthesize high temperature phase 
stabilized βTCP and HA/βTCP powders for plasma spray coating 
applications and fabricate HA/βTCP based coatings for the development of 
implantation processes.   
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Chapter 2: Materials and Methods 
 
In the past, calcium phosphate powders were mainly prepared by three 
methods: solid-state synthesis, wet chemical method and hydrothermal 
route. Among these methods the solid-state synthesis allows an excellent 
composition control. Therefore, it is the most common method for the 
preparation of calcium phosphates [63]. Other synthesis methods require 
obeying several strict processing conditions like reaction temperature, 
time and solution pH; a slight variation of any of these conditions can 
cause the formation of other phosphate phases, which are undesirable.[29, 
33, 35, 51] The synthesized powders find application in plasma spray 
coating for orthopaedic implants. The methods and procedures which used 
for the production of βTCP and HA/ βTCP plasma sprayed samples are 
explained below.   
2.1. Solid state synthesis method 
 
2.1.1. MgO-doped βTCP powder 
 
MgO-doped TCP powder was synthesized by conventional solid-state 
reaction method. High-purity CaHPO4.2H2O (brushite- Sigma-Aldrich, 98%) 
and CaCO3 (calcium carbonate-Sigma-Aldrich, 99%) with average grain size 
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of 5μm, were used in a molar ratio 2:1. The two raw powders and different 
amounts (0-14 mol%) of MgO (magnesium oxide- Farve s.r.l. Laboratories 
Pharmaceutics, 98.8% m) were mixed using a mortar and pestle, and 
further ethanol is added to obtain a homogeneous mixture. The obtained 
slurry was dried at 1000C for 12h before being transferred into an alumina 
crucible (capacity =50ml), subjected to heat treatment at 1000 – 1300⁰C 
for 2-12h and then freely cooled down to room temperature within the 
furnace. 
2.1.2. HA/βTCP (60:40) composite powders 
 
The HA/βTCP powders were synthesized using solid state method. 
Hydroxyapatite (HA) powder (Eurocoating, Italy) and 2 mol% MgO doped 
βTCP powders were used in 60:40 weight ratios. The as-received HA 
powder was heat treated at 1300⁰C/2h and mixed with βTCP using ethanol 
for homogenisation.  The obtained slurry was dried at 1000C for 12h before 
being transferred into an alumina crucible (capacity =50ml), subjected to 
heat treatment at 1300⁰C for 2 hand then freely cooled down to room 
temperature within the furnace. 
From the above synthesized powders, three powders were selected for the 
plasma spray process (Thanks to the collaboration with Eurocoating 
spa). The 1 mol% MgO doped βTCP powder is named as ‘A’, 2% MgO 
doped βTCP powder as ‘B’ and HA/βTCP (60:40) is named ‘C’. 
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Crystalline phase analysis was carried out by X-ray diffraction (XRD) (Rigaku 
DMax - Bragg-Brentano configuration). The measurement conditions were: 
range, 2 theta = 20-50°; step = 0.05⁰; fixed time = 6 s; radiation = CuKα. 
The crystallite size of the powders was calculated by the Scherrer equation 
[64–66] 
crystallite size = 0.9 λ / b cosθ    (1) 
where λ = X-ray wavelength, θ = Bragg diffraction angle and b = X-ray peak 
broadening. The value of b was measured from the highest intensity peak 
width at half height. 
The quantitative analysis of the samples was carried out by a computer 
software MDI-JADE and MAUD[21]. 
Fourier transformation - IR spectroscopy (FTIR) - Avatar 330 –Thermo 
Optics - spectra was recorded in transmission mode on KBr pellets, 
collecting 64 scans in the 4000-400 cm-1 range, with 4 cm -1 resolution. 
Thermo-differential analysis (DTA) - Netzsch, STA409- was carried out up to 
1500°C using alumina crucibles with α-alumina powder as reference.  The 
analysis was performed in static air with heating and cooling rates of 
10⁰C/min. To explain some peaks obtained in the DTA curves, βTCP pellets 
were also prepared for successive observations with Scanning Electron 
Microscope (SEM) (Jeol, JSM 5500). The synthesized powder was uni-
  
 Page 35 
 
axially pressed using 13mm diameter die at 10 MPa pressure and subjected 
to heat treatment at 1500⁰C with a heating rate 10⁰C/min. Then the pellets 
were placed on a conductive adhesive tape over the aluminium sample 
holder. After being coated with a thin layer of Au-Pd layer by sputtering, 
the samples were inserted in the SEM chamber and observed at various 
magnifications by using 20 kV acceleration voltages. 
Chemical analysis of the raw powders was carried out by inductively 
coupled plasma - atomic emission spectroscopy (ICP-AES) after the 
dissolution of a small amount of powder dissolved in hot 5wt% HNO3 water 
solution and analysed using the instrument. Ultra pure (99.99%) 
hydroxyapatite (HA) powder was used as standard for Ca and P; a multi 
element standard (sol.IV, Merck) was used for the detection of the other 
elements.  
After the heat treatment the powder was grinded using agate mortar.  
For the granulation process, the powder was kept on a rotating surface and 
water-binder (B-1000, 5%) mixture was sprayed over it. The βTCP granules 
were collected and dried at 100oC. The dried granules were sieved using 
100-150 μm sieve. Then the powder was heat treated at 1100 0C for 2h 
with 20C/min for the removal of binder. The heat treated powder was 
sieved and characterized by SEM, XRD and FT-IR.  
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For measuring the flowabilty of the granulated powders, a certain amount 
of powder was used for measuring the flow rate by the use of the Hall 
flow-meter funnel, by adapting the procedure described in ASTM B213 
norm.  As the powder does not flow unaided through the Hall flow-meter 
funnel; the funnel was connected to the columns of a sieve shaker - 
Endecotts Ltd, EVS-1 - operating at 60 and 80 Hz at a height of 16 cm from 
the base, thus aiding the flow of the powders though the orifice (2.54 mm 
diameter) of the funnel. The powder was poured in the funnel and the 
time required to exit completely from it was recorded.  The Hall flow rate 
was evaluated using the equation given below:  
       (1) 
t being the flow time for 25 g of powder (instead of 50 g as in ASTM B213 
norm due to the limited density of the powders considered here). Figure 7 
shows the images of flowabilty measurement. 
 
 
 
 
 
 
FR
H
* = t / 25g
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Figure 7: Flowabilty measurement 
The apparent density of the powders was measured by using a procedure 
similar to that described in ASTM B703 - UNI EN 23923-2 norms by using a 
35 ml cylinder. 
From the synthesized powders, three types of calcium phosphate powders 
were selected for the plasma spray process. That are 1 mol% MgO doped 
βTCP, 2 mol% MgO doped βTCP and HA/βTCP composite powder.  
The granulated powders were used for plasma spray coating process. 
During the process, the β phase of TCP is transformed into α phase. For 
analysing the stability of α phase obtained in the coatings, the coated 
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samples were subjected to thermal treatment at different temperatures 
and holding time. The plasma sprayed samples were heat treated at 500-
1100⁰C for 15 min to 2h and then freely cooled down to room temperature 
within the furnace. After the thermal treatment the samples were 
characterized using SEM, XRD, FT-IR, ICP analysis etc.  
2.2. Invitro analysis 
 
2.2.1. Bioactivity behaviour 
 
In vitro bioactivity properties were analysed by soaking the plasma spray 
coated samples in SBF at 37⁰C for 1 – 4 weeks. The calcium phosphate 
coatings obtained after thermal treatment was used for the bioactivity 
measurements. The average coating thickness of the sample is 80 - 90 μm. 
2 cm slices were cut from the plasma sprayed samples and were immersed 
in 50 ml SBF for 1- 4 weeks. For the preparation of SBF solution same 
method used in Oyane et al. [67] 
All the apparatus used for the preparation of the SBFs was washed with 
1.0M HCl and ultra pure water. 700 ml of double distilled water was 
poured in to a 2000 ml beaker, and stirred using a magnetic stirrer at 37⁰C. 
The temperature was measured using a laboratory thermometer. Once the 
liquid temperature reaches 37⁰C, the reagents were dissolved in water in 
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the sequence listed in the Table 5. The HEPES buffer was previously 
dissolved in 100 ml distilled water before adding to the solution. [4] 
Reagent Purity / % Amount 
Nacl >99.5 5.403 g 
NaHCO3 >99.5 0.740 g 
Na2CO3 >99.5 2.046 g 
KCl >99.5 0.225 g 
K2HPO4.3H2O >99 0.230 g 
MgCl2.6H2O >98 0.311 g 
HEPES >99.9 11.929 g 
CaCl2 >95 0.293 g 
Na2SO4 >99 0.072 g 
0.1M NaOH - 0.8 ml 
 
Table 5: Reagent, purity and amounts for preparing 1000 ml of SBF 
solution 
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2.2.2. Solubility Measurements 
 
pH 5.5MES buffer solution: 1.0 mol MES [2-Nmorphplino) ethane sulfonic 
acid] having a pH of 5.5 at 37°C and containing 8x10–5 mol NaCl, 8x10–5 mol 
CaCl2, and 5x10
–5mol K3PO4 and sodium azide (0.1 wt %) as bacteriostat. pH 
is adjusted to 5.5 by addition of 0.1 mol NaOH solution. 
100 mg of coating is added to 100 cm3 of each buffer solution (solid/liquid 
ratio of 1 mg/ml). This suspension is equilibrated in capped 250 cm3 
polyethylene bottles and kept at 37.0 ± 0.1 °C with a continuous shaking. 
Estimated equilibration time is 4 weeks (28 days). The pH of each 
suspension is obtained each day. The pH measurement is carried out in the 
suspensions in original bottles shaken in a bath at 37°C. The measurements 
in standard buffer solutions are done in the same manner, and they are 
carried out before, in between and after sample measurements. Each day 
a volume about 0.5 ml to 1 ml (volume depends on the concentration of Ca 
and P determined on the previous day) of suspension will be taken from 
the bottle using ICP. 
 
 
 
 
 
 
  
 Page 41 
 
Chapter 3: Results and Discussions 
 
3.1. Solid state Synthesis 
3.1.1. MgO doped βTCP powder 
 
MgO-doped TCP powder was synthesized by the solid-state reaction 
method. The aim of the present work is to produce high temperature 
phase stabilized βTCP powders and evaluate the maximum chemical 
substitution of Mg2+ in βTCP structure as a function of synthesis 
temperature. 
Mineralogical analysis of the synthesized powders 
 
The XRD patterns of MgO-doped TCP powder synthesized at different 
temperatures (1000-1300⁰C/2h) are shown in Figure 8. The narrow peaks 
observed in the spectra represent the crystalline nature of the powders 
and correspond to βTCP phase with rhombohedral crystal structure 
(whitlockite - 009-0169) [28,39,68]. For 1000 and 1100⁰C synthesis 
temperature, no extra peaks are observed and this suggests that only βTCP 
phase is obtained for any MgO additions (1-14 mol %) at such synthesis 
temperatures. This observation is in agreement with previous studies 
[32,41]. Conversely, for synthesis temperature of 1200 and 1300⁰C an 
  
 
 
additional peak is detected at 2θ=31.7⁰ starting from 5 mol% MgO doping; 
such peak corresponds to hydroxyapatite (HA- Ca5(PO4)3(OH) 
phase. The quantitative analysis of the crystalline phases allows 
estimate a consistent increase in HA phase concentration with MgO doping 
at 1200 and 1300°C/2h synthesized samples. 
Figure 8: Crystal structure of hydroxyapatite after Wilson et al. projected 
perpendicular to c-axis. (b) Crystal structure of hydroxyapatite after 
Wilson et al. projected on (001). [7] 
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Figure 9 reports the HA amount as a function of MgO concentration in TCP 
powders synthesized at 1300°C for 2h as calculated by MAUD software.
shows that βTCP is the only crystalline phase up to 2 mol% doping and a 
significant concentration of 8 wt% HA phase is observed in 5 mol% MgO
doped TCP powders. For 14 mol% MgO-doped powders, the percentage of 
HA are 15%. Also the TCP powder synthesized at 1200°C for
similar behaviour and these points out that an increase in dopant 
concentration increases the formation of HA phase. 
 
 
 
 
 
 
 
 
 
Figure 9: Hydroxyapatite (HA) content as a function of MgO addition in 
powder synthesized at 1300⁰C for 2h. 
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As shown in Figure 8 (c), at the highest doping levels (8 and 14 mol %) for 
synthesis temperature of 1200⁰C, an additional peak at 2
observed, which corresponds to MgO (Periclase-45-0946). For the 
Synthesis temperature of 1300⁰C, the MgO peak begins to app
lower MgO concentration (1 – 5 mol %). Presumably, the separate MgO 
peak corresponds to reaching the solubility limit and thereby to the 
segregation as third phase at such synthesis temperatures. Conversely, at 
lower processing temperature (1000 and 1100⁰C), there is no un
MgO for doping loads up to 14 mol%. 
 
 
 
 
 
 
 
 
Figure 10: XRD analysis of βTCP powders synthesized at 1300
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The presence of HA in the powders obtained after 2 h treatment shall be 
considered as a reaction intermediate only.  In fact, no HA peaks can be 
detected in XRD spectra recorded on powders synthesized at 1300°C for 12 
h (Figure 10). FT-IR analysis confirms the formation of HA phases in the 2h 
synthesized samples and its dehydroxylation after 12h treatment
 
Figure 11: FT-IR spectra of 8 mol% MgO-doped βTCP synthesized at 
1300⁰C for 2h and 12h. 
 
Page 45 
. 
  
 Page 46 
 
Figure 11 shows the FT-IR patterns of 8 mol% MgO-doped βTCP powder 
synthesized at 1300⁰C for 2h and 12h: weak OH vibration peaks can be 
detected at 3575 cm-1only for the 2 h treatment sample.  On the other 
hand, the FTIR spectra of 12h synthesised sample shows the disappearance 
of OH vibrational peak at 3575 cm-1 and confirms the instability of HA 
phase.   
The results obtained in the present work point out a certain disagreement 
with results previously reported, especially in Ref. [32].  The use of 
different raw materials and experimental conditions can account for such 
discrepancies.  Nevertheless, additional analysis and studies are certainly 
required to clarify them.  
A magnified portion of the XRD spectrum for pure and 8 mol% MgO-doped 
samples synthesized at 1300⁰C is shown as an example in Figure 12.  It 
shows a clear shift of the peaks towards higher 2θ values for MgO doped 
βTCP samples. This peak shift is indicative of variations in the lattice 
parameter, which occurs because of the incorporation of Mg2+ ions into 
the Ca2+ sites of the host lattice. Also the width of the peaks is different, 
also demonstrating a change in the crystalline size. 
 
 
  
 
 
Figure 12: Peak shift due to the incorporation of 8 mol% Mg
βTCP lattice. 
The variations in the lattice parameters and crystallite size affected by the 
addition of Mg2+ are reported in Table 6 and Figure 13. 
temperature of 1300°C, there is a consistent decrease in the lattice 
parameters ‘a’ and ‘c’ with MgO doping; up to 8 mol% and higher 
concentration the values remain constant. This decrease is associated with 
the substitution of Ca2+ ion (ionic radius: 0.9Å) by smaller Mg2+
crystallite size of the doped sample is shown to follow the sam
more evident trend. At lower synthesis temperature the lattice parameters 
‘a’ and ‘c’ show also a consistent decrease with MgO content. At 1200
the lattice parameters ‘a’ and ‘c’ decrease from 10.44 Å to 10.39Å and 
37.45Å to 37.3Å, respectively. 
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Table 6: Effect of MgO content on the lattice parameters and crystallites 
size of βTCP synthesized at 1300⁰C. 
 
 
  
 
 
Figure 13: Effect of MgO incorporation on the lattice parameters of 
synthesized at 1300⁰C. 
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Thermal behaviour 
Figure 14: DTA of βTCP powder synthesized at 1200 and 1300
Figure 14 shows the DTA plot of pure and 1 mol% MgO
powder synthesized at 1200 and 1300°C. The plot represents the 
behaviour on heating and cooling. For pure βTCP an endothermic peak is 
observed at 1280⁰C upon heating where as no exothermic peak is shown in 
the same temperature range upon cooling in both the cases; such peak can 
be associated to the β to α phase transformation of pure TCP. Also in 
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previous studies, such phase transformation is reported by an endothermic 
peak although observed at lower temperature (1180⁰C). In addition, no 
peak has been reported upon cooling around ~1180⁰C this pointing out the 
low temperature stability or meta-stability of the α phase [32]. The 
difference in the transformation temperature observed here with respect 
to previous results can be associated with the presence of Mg2+ in the 
powder precursors as impurity. As a matter of fact, ICP analysis of powder 
precursors (brushite and CaCO3) revealed the presence of 0.32 mol% Mg
2+ 
ions as impurity (no other impurities were found in concentration larger 
than 50 ppm).  Similar observations on the transformation temperature 
associated with the presence of Mg impurities are also reported in other 
papers[29]. For 1 mol% MgO-doped βTCP no endothermic peaks are 
observed up to 1400⁰C and this can be associated with the stabilization of 
β phase at high temperature due to MgO doping. Similar behaviour was 
also observed for βTCP powders containing higher amount of MgO and at 
lower processing temperature. 
In Figure 14 an endothermic peak centred at 1465⁰C and an exothermic 
one at 1439⁰C are also evident on heating and cooling curves, respectively. 
These could be associated either to α to α’ phase transformation or to a 
melting-solidification process whose nature is any how obscure with the 
data available here. Also in the present case a certain disagreement is 
pointed out with respect to previous studies although the impurity of the 
raw materials can only partially account for it.  To analyse the possible 
  
 
 
melting-solidification process, the TCP pellets were used for SEM analysis. 
Figure 15 shows SEM micrographs of pure βTCP pellets synthesized at 
1300°C and then treated at 1500⁰C: a fully dense morphology with 
properly connected grains of average size around 5μm. Conversely, the 
grain boundaries are not clearly visible in the sample treated at 1500°C and 
the microstructure resembles that obtained after a liquid ph
phenomenon, with rounded pores and grains. On this bas
recorded at 1465°C (heating) and 1435⁰C (cooling) in the DTA plots could 
be associated to a partial melting-solidification process. 
 
Figure 15: SEM images of synthesized and heat treated pure 
Samples with higher MgO concentrations could not be investigated by 
thermal analysis method since 1 mol% Mg2+ delays the transformation 
temperature above 1500⁰C, which is the limit of the instrument used in the 
current work.  
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The thermal stability of MgO-doped powders synthesized at 1300°C was 
analysed by high temperature treatments. Some samples were therefore 
heat treated at 1500⁰C for 4h and then analysed by XRD. The phase 
composition of the samples after heat treatment is shown in Table 7. Pure 
TCP powder contains 17.7% ‘α’ phase, whereas samples doped with 1 
mol% and above consist of β phase only at 1500⁰C. In samples with MgO 
concentration of 8 mol% and above, a mixture of βTCP phases and MgO is 
observed, which confirms the reaching of the solubility limit of MgO in the 
βTCP which is lower than that previously proposed. [32] 
 
 
 
 
 
 
Table 7: Mineralogical composition of βTCP powder synthesized at 
1300°C for 2 h and heat treated at 1500°C. 
Based on the previous reports on the cyctotoxicity of excess Mg content, 
we decided to further explore the work with lower concentration of Mg (1 
and 2 mol%).  
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3.1.2. HA/βTCP composite powders 
 
The HA/βTCP composite powder was produced by the mixing of HA 
powder and high temperature phase stabilized βTCP powder (2% MgO 
doped βTCP). The obtained powders were characterized using 
conventional techniques.  
The XRD pattern of as received and heat treated HA raw material used for 
the production of HA/βTCP composite a powder is shown in figure 16. The 
spectrum is matching with JCPDS. No. Hydroxyapatite - 09-432 – 
Ca5(PO4)3OHphase. The spectra clearly show the crystalline nature of the 
powder with respect to the effect of temperature. That is the heat treated 
powder has more crystalline nature compared to the as received HA 
powder.  The crystalline size of the powder also increases with increase of 
temperature. The as-received and heat treated HA, crystal size calculated 
by Scherrer equation are 9.7 nm and 40 nm respectively, and this is due to  
the grain growth of HA crystals during high temperature treatment.  
 
 
 
 
 
  
 
 
Figure 16: XRD spectrum of as received and heat treated HA powder
 
The treated HA powders are used for the preparation of HA/
composite powders. In the XRD spectrum (figure 17) of
HA/βTCP powders both the phases of HA and βTCP can be observed 
clearly. The peaks obtained at 2θ value 31.8⁰ is matching with 
intensity peaks (2 1 1) of HA (Hydroxyapatite - 09-432 – Ca5(PO
peak value at 31.1⁰ is (0 2 1)of βTCP (whitlockite- 09-0169- Ca
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Figure 17: XRD spectrum of synthesized HA/βTCP powder 
 
The quantitative analysis of each phase obtained after MAUD 
explained in figure 18 and table 8. From MAUD analysis it is evident that
HA phase is 59% and βTCP is 41%.  
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Figure 18: XRD plot obtained after MAUD analysis 
 
 
 
 
 
Table 8: Percentage of considered phases obtained after MAUD analysis 
Powder HA βTCP αTCP 
HA/βTCP 59.1 40.9 0 
  
 
 
3.1.3. Granulation of synthesised powders for plasma spray
 
The powders were produced with a view for the utilisation in
coating. The irregular shape of the synthesized powders (figure 
satisfying the required properties for plasma spraying machine. 
spraying the powders should be within the granulometric size of 100
150μm.  
Figure 19: SEM images of the powders before granulation 
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For obtaining specific properties, the synthesized powders we
to granulation process. After the granulation process, the particles are 
agglomerated and a uniform shape was obtained in the size
150μm. Figure 20-22 shows the SEM images of the granulated powders. 
Three different types of powders were used for the granulation process 
and plasma spray coating. The 1 mol% MgO doped βTCP powder 
as ‘A’, 2% MgO doped βTCP powder as ‘B’ and HA/βTCP (60:40) 
‘C’. 
 
Figure 20: SEM images of the sample A after granulation process
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Figure 21: SEM images of the sample B after granulation process
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Figure 22: SEM images of the sample C after granulation process
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3.1.4. Properties of granulated powders 
 
The phase compositions of the granulated powders obtained by MAUD 
analysis is shown in table 9. 
 
Powder HA βTCP αTCP 
A 0 100 0 
B 4 96 0 
C 59.1 40.9 0 
 
Table 9: Phase composition in each sample after MAUD analysis 
 
Powder ‘A’ shows 100% purity in βTCP phase; conversely powder ‘B’ 
contains 96% βTCP and 4% HA. The formation of HA in MgO doped βTCP 
powders has been previously explained.  
The Infrared spectra of considered samples are shown in figure 23. The 
vibrations obtained 473, 570 and 605 cm-1 corresponds to PO4
3- groups. 
The peak obtained at 3570 cm-1 in powder C represents the OH stretching 
  
 
 
of HA. In samples ‘A’ and ‘B ’no such kind of vibrations was observed
though powder ‘B’ shows small amount (4%) of HA phase in XRD. 
Figure 23: FT-IR spectrum of considered sample before plasma spray 
process 
 
The strong bands in the IR spectrum can be attributed to PO4
band at 1050cm-1is due to the components of triply degenerated anti 
symmetric P-O stretching mode. The peak at 962 cm-1
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degenerated P-O symmetric stretching mode. The bands at 605cm-1and 
570 cm-1 are assigned to the components of triply degenerated O-P-O 
bending mode. Absence of any distinct band in the range of 1400-1550  
cm-1 indicates that the samples do not contain large quantities of 
carbonate ions. The band due to the hydroxyapatite OH stretching 
vibrations at 3570cm-1 is visible on the FT-IR spectra corresponding to the 
HA containing sample C.IR spectrum contains some features according to 
βTCP phase observed from the band shoulders around  947, 974 and 1120 
cm-1 in sample ‘A’ and ‘B’. A very weak peak is obtained at this range 
because of the presence of HA in sample C.[69, 70] 
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3.1.5. Flowabilty and density 
 
The flowabilty and density are important factors for powders which are 
used in plasma spray process. The measured properties are reported in 
table 10 
It is evident that powder ‘A’ shows better flowabilty rates compared to the 
other two powders because of the high bulk density. Higher MgO 
concentration reduces the bulk density. Ca/P ratio was obtained by ICP 
analysis. Sample ‘A’ and ‘B’ show Ca/P ratio as 1.47 and 1.49 respectively in 
good agreement with previous reports. In powder ‘C’ the obtained ratio is 
1.58, because of the presence of both the phases of HA and βTCP.  
Powder Frequency 
(Hz) 
Time 
(s) ±5 
FRH 
±0.2 
Bulk 
density(g/cm
3
) 
Ca/P 
ratio 
A 80 74 2.96 1.1 1.47 
60 78 3.12 
B 80 113 4.52 0.8 1.49 
60 170 6.8 
C 80 109 4.36 0.8 1.58 
60 122 4.88 
Table 10: Flowabilty and bulk density of the powders 
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The powders were used in the plasma spray machine (sample A, B and C) 
and coated on Ti surface. Figure 24 show the images of the plasma sprayed 
coatings. Sample D is the pure HA plasma sprayed coating obtained from 
Eurocoating spa. The synthesized powders show good performance in the 
plasma spray machine and coatings are uniform. 
 
Figure 24: Images of plasma sprayed samples 
 
 
  
 
 
3.1.6. Properties of CaP based plasma sprayed coatings
 
XRD spectra obtained after plasma spray process is shown in 
the phase composition of each phase (calculated using MAUD) 
table 11. 
 
 
 
 
 
 
 
 
 
 
Figure 25: XRD spectra of considered samples after plasma spray process
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The XRD spectra of sample ‘A’ and ‘B’ are matching with JCPDS. No. 09-348 
– Ca3(PO4)2OH (αTCP) phase. The higher intensity peak observed at 2θ= 
30.7⁰ is the (1 7 0) phase of αTCP. This indicates that, after plasma spray 
process the β phase of TCP is transformed to α. The βTCP phase in sample 
‘C’ also follows the same trend. The quantitative analysis of the samples 
obtained after MAUD analysis is shown in the table 11. 
 
In the case of sample ‘A’, the β to α phase transformation is 67% and 
78.5% in ‘B’. But in ‘C’, after plasma spray 47.3% of HA, 45.2% of α phase 
and only 7.5 % of β is obtained. The initial powder had 60% of HA phase 
and 40% βTCP phase which implies that after plasma spray HA phase also 
shows some phase transformation to αTCP.  
Powder HA βTCP αTCP 
A 0 33 67 
B 1.5 20 78.5 
C 47.3 7.5 45.2 
Table 11: Percentage of phase compositions of the samples after plasma 
spray obtained after MAUD analysis 
  
 
 
From the observations, during the plasma spray process, the 
temperature phase stabilized βTCP powders also changed their phase 
TCP due to the very high temperature formation and fast cooling rate
FT-IR spectra of plasma sprayed samples are shown in figure 
 
Figure 26: FTIR spectra of considered samples after plasma spray
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After plasma spray the βTCP peaks of initial samples are completely 
disappear and the small vibrations observed at 603, 1032 and 1072 cm-1 
indicates the formation of αTCP phase in all the samples. The OH 
vibrational peaks of HA is obtained at 3572 cm-1 in sample ‘C’. The 
vibrations observed at 477, 566 and 609 cm-1 corresponds to PO4
3- groups 
and a small shift of PO4
3-vibrations can be seen after plasma spray. [69][70] 
ICP analysis also shows small variations in Ca/P ratio from the initial 
results. The Ca/P ratio decreases from 1.47 to 1.45 in sample ‘A’, from 1.49 
to 1.43 in ‘B’ and 1.58 to 1.51 in sample ‘C’. This may be due to the phase 
transformation of TCP or melting of samples during plasma spray process.  
SEM analysis of the coated sample cross section reported in figures 27- 29. 
They reveal that the coatings are uniform and well adherent with Ti 
substrate. The average coating thickness of the coatings is ~ 80 – 90 μm. 
For taking the cross sectional SEM images, the sample were moulded in an 
epoxy resin (Epofix resin and Epofix hardner in 5:1 ratio). 
 
 
 
  
 
 
 
 
 
 
Figure 27: Cross section images of ‘sample A’ coated on Ti surface
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Figure 28: Cross section images of ‘sample B’ coated on Ti surface
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Figure 29: Cross section images of ‘sample C’ coated on Ti surface
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The melting of the samples can be clearly understood from the SEM 
images of the coated surface. Figure 30 - 32 shows the surface SEM images 
of considered samples on the Ti surface.  
 
 
Figure 30: Surface SEM images of Sample ‘A’ coated on the Ti surface 
 
Figure 31: Surface SEM images of Sample ‘B’ coated on the Ti surface 
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Figure 32: Surface SEM images of Sample ‘C’ coated on the Ti surface 
As shown before, after plasma spray the β phase of TCP is transformed to 
α phase due to the very high temperature and fast cooling rate during the 
process. For analysing the stability of the obtained α phase after plasma 
spray coatings, the coatings were subjected to heat treatment in between 
the temperature range 500-1100⁰C for 15 min to 2h. After the thermal 
treatment the coatings were characterized using XRD, SEM, ICP and FT-IR. 
The properties of coatings obtained after thermal treatment is explained 
below.  
 
 
 
  
 
 
3.1.7. Properties of coatings after thermal treatment
 
Initially, the Sample ‘B’ was used for the thermal treatment process. 
XRD spectra of 2% MgO doped (B) coatings after thermal treatment
shown in figure 33. The spectra clearly indicate the reverse phase 
transformation of βTCP with respect to temperature.   
 
Figure 33: XRD spectra of coating heat treated at different temperatures
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The percentage of each phase formation during thermal process obtained 
from MAUD analysis is given in Table 12. The table shows that the 
reversible phase transformation of ‘αTCP with respect to the increase of 
temperature. At 800⁰C the ‘α’ phase is completely removed and obtained 
βTCP and HA. 
 
Temperature (⁰C) HA βTCP αTCP 
500 3.1 15.8 80.9 
600 15.5 43.3 41.2 
700 14.4 81.1 4.0 
800 16.9 83.1 0 
900 8.9 91.1 0 
1000 3.0 97,0 0 
1050 0 100 0 
 
Table 12: phase composition after each specific thermal treatment 
  
 
 
The phase transformation of α to βTCP is again confirmed with DTA 
analysis. Figure 34 shows the DTA spectra of plasma sprayed TCP powder
of Sample B.  
Upon heating, an endothermic peak is observed at 550⁰C, 
attributed to α to β phase transformation of plasma sprayed TCP. 
DTA results are matching with the XRD results which we obtained during 
the heat treatment.  
 
 
 
 
 
 
 
 
Figure 34: DTA spectrum of plasma sprayed samples
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From the XRD and DTA spectra, the temperature range in between 700 and 
800⁰C shows the complete phase transformation temperature of α to β 
TCP. Ti surface shows some kind of oxidation process above 850⁰C. [71–73] 
So the temperature has to be fixed at 800⁰C to obtain TCP coatings without 
α phase. Based on this inference all other coatings were heat treated at 
this temperature for removing the unwanted phase like α.  
 
Table 13 shows the phase compositions of each phase obtained after 
successful thermal treatment of CaP based coatings. It explains that at 
Powder Temperature (⁰C) HA βTCP αTCP 
 
A 
600 10.5 48.7 40.8 
700 12.1 84.1 3.8 
800 14.2 85.8 0 
 
B 
600 15.5 43.3 41.2 
700 14.4 81.1 4.04 
800 16.9 83.1 0 
 
C 
600 67.7 16.7 15.7 
700 70.4 27.9 1.7 
800 72.0 28 0 
Table 13: Percentage of phase transformation of α to β with temperature 
obtained from MAUD analysis 
  
 
 
800⁰C, α phase was completely removed and HA and βTCP was obtained. 
In powders A and B, 14 and 16% HA phases are obtained respectively. In 
powder C, HA phase id 72% and βTCP phase is 28%.  
 
 
 
 
 
 
 
Figure 35: FT-IR spectrum of coatings after thermal treatment at 800
In the IR spectrum (figure 35), after the thermal treatment 
reappeared at 1115, 980 and 960 cm-1 in samples ‘A’ and ‘
vibrations confirm the formation of βTCP during thermal treatment. 
OH vibrational peaks of HA is observed at 3561 and 3563 cm
‘B’ and ‘C’. The vibrations observed at 464, 552 and 608 cm-
to the PO4
3- groups present in the considered samples.  
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The SEM images of the sample cross section after thermal treatment 
(figure 36-38) reveal that, the coatings do not show any change compared 
with initial coatings. Samples are uniform in nature and are in good contact 
with Ti surface after thermal treatment also. The average coating thickness 
of the coatings is ~ 80 – 90 μm. 
Figure 36: Cross section images of sample ‘A’ coated on Ti surface after 
thermal treatment. 
Figure 37: Cross section images of sample ‘B’ coated on Ti surface after 
thermal treatment. 
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Figure 38: Cross section images of sample ‘C’ coated on Ti surface after 
thermal treatment 
The βTCP and HA/βTCP coatings were successfully fabricated using plasma 
spray and successful thermal treatment.  
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3.1.8. Invitro studies of TCP coatings 
 
3.1.9. Bioactivity behaviour 
 
The bioactivity behaviour (leaching) of the plasma sprayed coatings were 
analysed using simulated body fluid for 28 days at 37⁰C.  After the studies 
the samples were investigated by SEM.  
Figures 39-41, shows the cross sectional SEM images of considered sample 
after the leaching studies in SBF solution for 28 days. The images shows, 
the outer most leached HA layer of approximately 30-40 μm thicknesses 
for all the samples and shows some cracking perpendicular to the interface 
indicating mechanical weakening due to leaching. The Ca/P ratio of the HA 
top coat has 1.37 for sample ‘A’, 1.38 for ‘B’ and 1.46 for ‘C’. Kurzweg et al 
reported about the new HA top coat formation during the leaching studies 
of plasma sprayed HA.[4] 
 
  
 
 
 
Figure 39: SEM images of sample ‘A’ after 28 days leaching process
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Figure 40: SEM images of sample ‘B’ after 28 days leaching process
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Figure 41: SEM images of sample ‘C’ after 28 days leaching process
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3.1.10. Solubility measurements 
 
The solubility measurements were carried out for 24 days in pH 5.5 MES 
buffer solution.  Every 4 day the concentration of Ca/P was analysed using 
ICP. Figure 42 shows the solubility trends of considered samples. Sample 
‘D’, represents the conventional HA coating, which obtained from 
Eurocoating spa, Italy. This we used for a comparative study with our 
newly prepared calcium phosphate coatings. 
The Ca and P concentrations obtained from ICP analysis are plotted against 
time.  
Figure 42 shows the Ca and P concentration during measurement period. 
The dissolution of the samples is completely depends on the chemical 
compositions and surface morphology of the coatings.   
In terms of dissolution of Ca and P, the order of solubility of most common 
calcium phosphate materials are: TTCP>> αTCP>>βTCP>> HA. [74] 
 
 
 
 
  
 
 
 
Figure 42: Ca and P concentations versus time: MES buffer solution at pH 
5.5 
 
In our studies, samples are following the same trend. Sample 
more solubility rate compared with ‘B’. This is mainly due to the presence 
of higher amount of MgO in sample ‘B’.  The Sample ‘C’
solubility rate higher than that of conventional HA coatings (sample D). 
From this observation the HA/βTCP shows better solubility rate than 
conventional HA coatings. [75][76] 
For the concentration product calculation same methods are used for all 
the samples, is due to the fact that, it is not possible to calculate the Ksp 
value of biphasic compounds. Sample A and B contains >10% of HA phase 
and it consider as biphasic calcium phosphate. Ksp depends on the 
particular formula of specific monophasic compound.  
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The results obtained after calculating the concentration product values are 
reported in Table 14. 
 
Plasma sprayed βTCP and HA/βTCP coatings were successfully fabricated 
using plasma spray method and thermal process. The coatings show good 
biological performance. The newly produced plasma sprayed coatings also 
obtained leached HA top coat formation in SBF solution after 28 days.  The 
solubility studies revels that the presence of βTCP increases the dissolution 
rates of HA and the HA/βTCP is more soluble than HA in MES buffer 
solution. The solubility behaviour of calcium phosphates in MES buffer 
solution is, TTCP>> αTCP>> βTCP>> HA/βTCP>> HA. 
Sample Ca/P ratio Concentration product 
[Ca
2+
]
10
[PO4
3-
]
6
 
A 1.45 1.95 X 1015 
B 1.47 1.13 X 1014 
C 1.53 4.3 X 1011 
D 1.64 0.6 X 102 
Table 14: Concentration product of coatings in MES solution 
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Chapter 4: Conclusion 
 
In the present work, βTCP and HA/βTCP coatings were successfully 
fabricated using plasma spray and successive thermal treatments. 
The βTCP and HA/βTCP powders were synthesized using solid state 
method and MgO is used as a phase stabilizer. The synthesized powders 
were characterized using XRD, SEM, TG/DTA, ICP etc. The obtained 
powders were granulated and used for the plasma spray coating process. 
After the coating process the β phase of TCP is transformed to α phase. For 
analysing the stability of obtained α phase, the coatings were subjected to 
the thermal treatment at 500-1100⁰C for 15 min. - 2h. At 800⁰C, the ‘α’ 
phase present in the plasma sprayed calcium phosphate coating is 
completely transformed to β phase and βTCP and HA/βTCP coatings are 
obtained. The successively produced coatings were characterized and the 
Invitro properties like solubility and bioactivity behaviours are measured. 
The bioactivity properties were analysed by soaking the plasma spray 
coated samples in SBF at 37⁰C for 1 – 4 weeks. After 4 weeks, new leached 
HA top coat layer with average thickness 30 – 40μm was observed in the 
surface of the coatings. 
 The solubility measurement was analysed with MES buffer solution for 24 
days. The solubility behaviour of calcium phosphates in MES buffer 
solution is, TTCP>> αTCP>> βTCP>> HA/βTCP>> HA. 
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Therefore the βTCP and HA/βTCP coatings were soluble faster than HA and 
slower than αTCP. The newly fabricated βTCP and HA/βTCP plasma 
sprayed coatings showed better biological performance in SBF and MES 
buffer solution.  
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